Fulgent Genetics, Inc. (FLGT) stock
FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3047% below fair value
$24.21+0.14 (+0.56%)
Close on Nov 17, 2026Market cap $666.15MP/E –Yield –
Fulgent Genetics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Fulgent Genetics's price to book ratio was 0.7× on Nov 11, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.4× to 2.9×, with a median of 0.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.7× | −0.0 |
| 2025 | Dec 31, 2025 | 0.7× | +0.2 |
| 2024 | Dec 31, 2024 | 0.5× | −0.2 |
| 2023 | Dec 29, 2023 | 0.7× | −0.0 |
| 2022 | Dec 30, 2022 | 0.7× | −2.2 |
| 2021 | Dec 31, 2021 | 2.9× | −3.6 |
| 2020 | Dec 31, 2020 | 6.5× | +2.1 |
| 2019 | Dec 31, 2019 | 4.4× | +3.3 |
| 2018 | Dec 31, 2018 | 1.1× | −0.3 |
| 2017 | Dec 29, 2017 | 1.4× | −7.2 |
| 2016 | Dec 30, 2016 | 8.6× | – |
See a number that looks wrong?